文献速递泌尿系感染膀胱癌与上尿路尿路上皮癌

EB病毒或为间质性膀胱炎持续膀胱炎症的潜在病因

Epstein-Barr Virus as a Potential Etiology of Persistent Bladder Inflammation in Human Interstitial Cystitis/Bladder Pain Syndrome.
PubMed 文献 · J Urol · 2018-04-11

本研究以间质性膀胱炎/膀胱疼痛综合征患者和压力性尿失禁对照的膀胱标本为对象,检测EB病毒编码RNA和DNA。结果显示伴Hunner病变患者EBER阳性率50%对8.6%,EBV DNA检出率68.8%对16.7%,对照组几乎阴性,EB感染主要局限于T淋巴细胞。

要点

  • 伴Hunner病变的IC/BPS患者膀胱EBER阳性率50%,无Hunner病变者8.6%,对照组无阳性。
  • qPCR检测EBV DNA在伴与不伴Hunner病变者中分别为68.8%和16.7%,对照仅1例阳性。
  • EB感染主要局限于膀胱T淋巴细胞,可能与IC/BPS持续炎症相关。

核心结论

  • 膀胱T细胞内的EB病毒感染可能与IC/BPS患者持续炎症的发病机制相关。

研究设计与样本

  • 纳入16例伴Hunner病变的IC/BPS患者、23例不伴Hunner病变的IC/BPS患者和10例压力性尿失禁对照,检测膀胱标本EBER、EBV DNA、血清学及免疫组化。

主要发现

  • 伴与不伴Hunner病变的IC/BPS患者膀胱EBER阳性率分别为50%和8.6%,对照标本无EBER阳性。
  • qPCR检测EBV DNA在伴与不伴Hunner病变者中阳性率分别为68.8%和16.7%,中位病毒载量为1,836拷贝/ml(范围216至75,144)。
  • 对照组仅1例标本qPCR检测EBV阳性。
  • IC/BPS患者血清学均显示既往EB病毒感染。
  • 伴与不伴Hunner病变者膀胱EBV感染率分别为87.5%和17.4%,全部IC/BPS患者合计46.2%。

临床怎么用

  • 对伴Hunner病变的IC/BPS患者,可考虑评估膀胱EB病毒感染作为炎症持续的可解释因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Interstitial cystitis/bladder pain syndrome is characterized by bladder inflammation without bacterial infection. Although viral infection is a potential etiological cause, few studies have been reported. MATERIALS AND METHODS: Bladder specimens were obtained from patients with interstitial cystitis/bladder pain syndrome and from patients with stress urinary incontinence as controls. Bladder specimens were tested for Epstein-Barr encoded RNAs by in situ hybridization and for Epstein-Barr DNA by quantitative real-time polymerase chain reaction, serology and immunohistochemical staining. RESULTS: Enrolled in study were 16 patients with interstitial cystitis/bladder pain syndrome and Hunner lesions, 23 without interstitial cystitis/bladder pain syndrome or Hunner lesions and 10 controls. The positive rate of Epstein-Barr encoded RNA on in situ hybridization in bladder specimens from patients with vs without interstitial cystitis/bladder pain syndrome and Hunner lesions was 50% vs 8.6%. No Epstein-Barr encoded RNA was found in control specimens. On quantitative real-time polymerase chain reaction Epstein-Barr DNA was detected in 68.8% vs 16.7% of bladder specimens in patients with vs without interstitial cystitis/bladder pain syndrome and Hunner lesions. The median viral load was 1,836 copies per ml (range 216 to 75,144). Only 1 control specimen was Epstein-Barr positive on quantitative real-time polymerase chain reaction. All serum samples from patients with interstitial cystitis/bladder pain syndrome showed past Epstein-Barr viral infection. Epstein-Barr infection was present in 87.5% vs 17.4% of bladder specimens from patients with vs without interstitial cystitis/bladder pain syndrome and Hunner lesions for a total of 46.2% with interstitial cystitis/bladder pain syndrome. Immunohistochemical staining of CD3 and CD20 revealed that Epstein-Barr infection was mainly restricted to T lymphocytes in bladders showing interstitial cystitis/bladder pain syndrome. CONCLUSIONS: Bladder Epstein-Barr infection in T cells may be linked to the pathogenesis of persistent inflammation in patients with interstitial cystitis/bladder pain syndrome.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Jhang JF, Hsu YH, Peng CW, et al. Epstein-Barr Virus as a Potential Etiology of Persistent Bladder Inflammation in Human Interstitial Cystitis/Bladder Pain Syndrome. J Urol. 2018. PMID: 29653163. doi:10.1016/j.juro.2018.03.133

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。